April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
The Role of Chemokine Decoy Receptor D6 on Leukocytes in Regulating Corneal Inflammation
Author Affiliations & Notes
  • A. R. Hajrasouliha
    Department of Ophthalmology, Harvard Medical School, Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Z. Sadrai
    Department of Ophthalmology, Harvard Medical School, Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • D. R. Saban
    Department of Ophthalmology, Harvard Medical School, Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • S. K. Chauhan
    Department of Ophthalmology, Harvard Medical School, Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • R. Dana
    Department of Ophthalmology, Harvard Medical School, Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  A.R. Hajrasouliha, None; Z. Sadrai, None; D.R. Saban, None; S.K. Chauhan, None; R. Dana, None.
  • Footnotes
    Support  NIH Grant R01-EY-12963
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 6142. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. R. Hajrasouliha, Z. Sadrai, D. R. Saban, S. K. Chauhan, R. Dana; The Role of Chemokine Decoy Receptor D6 on Leukocytes in Regulating Corneal Inflammation. Invest. Ophthalmol. Vis. Sci. 2009;50(13):6142.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : D6 is a decoy receptor which functions to regulate immunity by scavenging numerous inflammatory chemokines (i.e. CCL2, CLL3, CCL4, and CCCL5). While D6 expression was first shown on lymphatic endothelial cells, it has also been shown on a variety of leukocytes as well. We therefore hypothesized that D6 expression plays a role in controlling inflammation in the cornea and dendritic cells (DCs) are important in mediating this response.

Methods: : Corneal inflammation was induced using the suture-model, whereby 3 intra-stromal sutures are placed in the paracentral cornea. Expression of D6 in normal and inflamed corneas as well as their draining lymph nodes was analyzed by RT-PCR out to10 days post-surgery. Additionally, the phenotype of D6-expressing cells was identified by flow cytometry via double-staining with various relevant cell-surface markers (i.e. CD45, CD3, CD11c and CD11b).

Results: : Infiltration of leukocytes (CD45+) into the cornea was detected 24 hours post-surgery and this was associated with a two-fold increase in D6 expression (p<0.05, as measured by RT-PCR). Moreover, these mice also exhibited on day 7 post-surgery, increased D6 expression on MHC II+ cells of the draining lymph node. Interestingly, D6 expression proved to be strongly enhanced in lymph node DCs (CD11c+) draining from inflamed corneas, as compared to the naïve controls (mean fluorescence = 139.5 vs. 97, respectively).

Conclusions: : Our data points to the possibility that D6 plays a role in controlling corneal inflammation, as it is strongly up-regulated during an inflammatory insult. Moreover, it appears that this level of regulation may be offered particularly by DCs, which appear to express the highest levels of this scavenger receptor. Future work is now aimed at testing this hypothesis in a D6 knock-out model, which we have recently acquired.

Keywords: cytokines/chemokines • immunomodulation/immunoregulation • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×